Nortech Systems Reports Q3 2025 Results

Estimated reading time: 1 minute

Nortech Systems Incorporated, a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the third quarter ended September 30, 2025.

2025 Q3 Highlights:

• Net sales of $30.5 million in Q3 2025 vs. $31.4 million in Q3 2024
• Net loss of $(146) thousand, or $(0.05) per basic share in Q3 2025 vs. $(739) thousand, or $(0.27) per basic share in Q3 2024
• Adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of $1.3 million in Q3 2025 vs. $0.1 million in Q3 2024
• 90-day backlog of $31.3 million as of September 30, 2025 vs. $29.6 million as of September 30, 2024

Management Commentary

“Nortech’s third quarter results reflect continued evidence our restructuring efforts combined with cost discipline are paying off. A planned positive shift from first builds to recurring production across programs transferred between our plants is due to increased manufacturing efficiencies. I am very proud of the entire team’s execution and focus to achieve our goals,” said President & CEO, Jay D. Miller.

“Further, we recently completed a significant regulatory milestone with our Monterrey, Mexico facility achieving AS9100:D certification.” Miller added, “This certification underscores Nortech’s capability to deliver complex, high-reliability products for demanding applications, enhancing our service offerings to both current and prospective clients in the aerospace and industrial markets. This achievement further supports our viewpoint that we are well positioned to continue to leverage our operational performance in the current nearshoring landscape with our North American and Asian footprint,” Miller said.